BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24973978)

  • 1. Modulation of age- and cancer-associated DNA methylation change in the healthy colon by aspirin and lifestyle.
    Noreen F; Röösli M; Gaj P; Pietrzak J; Weis S; Urfer P; Regula J; Schär P; Truninger K
    J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24973978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal analysis of healthy colon establishes aspirin as a suppressor of cancer-related epigenetic aging.
    Noreen F; Chaber-Ciopinska A; Regula J; Schär P; Truninger K
    Clin Epigenetics; 2020 Nov; 12(1):164. PubMed ID: 33143725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes.
    Amitay EL; Carr PR; Jansen L; Walter V; Roth W; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
    J Natl Cancer Inst; 2019 May; 111(5):475-483. PubMed ID: 30388256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors.
    Figueiredo JC; Grau MV; Wallace K; Levine AJ; Shen L; Hamdan R; Chen X; Bresalier RS; McKeown-Eyssen G; Haile RW; Baron JA; Issa JP
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1041-9. PubMed ID: 19336559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermediate- and low-methylation epigenotypes do not correspond to CpG island methylator phenotype (low and -zero) in colorectal cancer.
    Karpinski P; Walter M; Szmida E; Ramsey D; Misiak B; Kozlowska J; Bebenek M; Grzebieniak Z; Blin N; Laczmanski L; Sasiadek MM
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):201-8. PubMed ID: 23175427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation.
    Greco SA; Chia J; Inglis KJ; Cozzi SJ; Ramsnes I; Buttenshaw RL; Spring KJ; Boyle GM; Worthley DL; Leggett BA; Whitehall VL
    BMC Cancer; 2010 Sep; 10():494. PubMed ID: 20846368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population-based study.
    Wang T; McCullough LE; White AJ; Bradshaw PT; Xu X; Cho YH; Terry MB; Teitelbaum SL; Neugut AI; Santella RM; Chen J; Gammon MD
    Cancer; 2019 Nov; 125(21):3836-3844. PubMed ID: 31402456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an episignature of human colorectal cancer associated with obesity by genome-wide DNA methylation analysis.
    Crujeiras AB; Morcillo S; Diaz-Lagares A; Sandoval J; Castellano-Castillo D; Torres E; Hervas D; Moran S; Esteller M; Macias-Gonzalez M; Casanueva FF; Tinahones FJ
    Int J Obes (Lond); 2019 Jan; 43(1):176-188. PubMed ID: 29717273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
    Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
    Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.
    Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H
    Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique patterns of CpG island methylation in inflammatory bowel disease-associated colorectal cancers.
    Olaru AV; Cheng Y; Agarwal R; Yang J; David S; Abraham JM; Yu W; Kwon JH; Lazarev M; Brant SR; Marohn MR; Hutcheon DF; Harpaz N; Meltzer SJ; Mori Y
    Inflamm Bowel Dis; 2012 Apr; 18(4):641-8. PubMed ID: 21830278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients.
    Draht MX; Smits KM; Tournier B; Jooste V; Chapusot C; Carvalho B; Cleven AH; Derks S; Wouters KA; Belt EJ; Stockmann HB; Bril H; Weijenberg MP; van den Brandt PA; de Bruïne AP; Herman JG; Meijer GA; Piard F; Melotte V; van Engeland M
    Mol Oncol; 2014 May; 8(3):679-88. PubMed ID: 24560444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging and DNA methylation in colorectal mucosa and cancer.
    Ahuja N; Li Q; Mohan AL; Baylin SB; Issa JP
    Cancer Res; 1998 Dec; 58(23):5489-94. PubMed ID: 9850084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa.
    Wallace K; Grau MV; Levine AJ; Shen L; Hamdan R; Chen X; Gui J; Haile RW; Barry EL; Ahnen D; McKeown-Eyssen G; Baron JA; Issa JP
    Cancer Prev Res (Phila); 2010 Dec; 3(12):1552-64. PubMed ID: 21149331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Colon-Specific DNA Methylation-Regulated Gene Modules on Colorectal Cancer Patient Survival.
    Yu H; Jiang W; Chen G; Yang F; Zhao X; Ji Z; Ni J; Fu Y; Chen F; Zhao B
    Med Sci Monit; 2019 May; 25():3549-3557. PubMed ID: 31083646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
    Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
    J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
    Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations.
    Kim YH; Lee HC; Kim SY; Yeom YI; Ryu KJ; Min BH; Kim DH; Son HJ; Rhee PL; Kim JJ; Rhee JC; Kim HC; Chun HK; Grady WM; Kim YS
    Ann Surg Oncol; 2011 Aug; 18(8):2338-47. PubMed ID: 21298349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.